HCFC2

HCFC2 is a nuclear transcriptional coregulator that functions in both chromatin modification and innate immune gene regulation. It is a subunit of the MLL/SET1 histone H3K4 methyltransferase complex, where it interacts with a conserved binding motif in the MLL(N) subunit (PMID:15199122, PMID:23508102). HCFC2 promotes IRF1 and IRF2 binding to innate immune gene promoters, including Tlr3, and is required for type I interferon and inflammatory cytokine responses to viral dsRNA; loss-of-function mutations in Hcfc2 compromise antiviral defense in vivo (PMID:28970238). Its kelch/beta-propeller domain supports VP16-induced complex assembly but, unlike HCF-1, does not efficiently drive VP16-dependent transcriptional activation, with selectivity determined by differences in the fifth and sixth kelch repeats (PMID:10196288, PMID:11711630).

1. 1999 High

   Identification of HCFC2 as a second HCF family member established that the kelch-repeat beta-propeller domain is a conserved VP16-interaction module, and chimeric analysis pinpointed the fifth and sixth repeats as the determinant of reduced VP16-association efficiency relative to HCF-1.

   Evidence Sequence homology cloning, co-IP, gel-shift, chimeric mutagenesis, subcellular localization imaging in human cells

   PMID:10196288

   Open questions at the time

   • Endogenous transcriptional targets of HCFC2 were unknown
   • Whether HCFC2 participates in chromatin-modifying complexes was untested
2. 2000 Medium

   Demonstration that HCFC2 contains a functional SAS1 self-association element, despite not undergoing proteolytic processing, showed that this module serves a broader association function beyond simply linking HCF-1 subunits.

   Evidence Deletion/mutagenesis analysis and co-IP domain mapping

   PMID:10958670

   Open questions at the time

   • The physiological binding partners recruited through the HCFC2 SAS1 element remain uncharacterized
   • No in vivo functional assay for HCFC2 SAS1 activity
3. 2001 High

   Separation of VP16-induced complex stabilization from transcriptional activation revealed that HCFC2 supports complex assembly but lacks the ability to drive transcription, demonstrating that these are genetically separable HCF functions.

   Evidence EMSA, co-IP, and transcriptional reporter assays

   PMID:11711630

   Open questions at the time

   • The structural basis for why HCFC2 fails to activate VP16-dependent transcription was not determined
   • Whether HCFC2 has independent transcriptional activation roles outside the VP16 context was unknown
4. 2002 Medium

   Conservation of the WYF–PDCD2 interaction between HCF-1 and HCFC2 linked HCFC2 to corepressor complex regulation, suggesting a shared mechanism through which PDCD2 modulates HCF family activity.

   Evidence Co-IP and complementation assay in tsBN67 cells with dominant-negative constructs

   PMID:12149646

   Open questions at the time

   • Functional consequences of PDCD2 interaction for HCFC2-specific targets were inferred from HCF-1 data rather than directly shown
   • No endogenous HCFC2-PDCD2 complex was isolated
5. 2004 High

   Biochemical purification of the MLL histone methyltransferase complex identified HCFC2 as a bona fide subunit, establishing its role in H3K4 methylation-associated transcriptional regulation.

   Evidence Endogenous complex purification by affinity chromatography, mass spectrometry, and co-IP from human cells

   PMID:15199122

   Open questions at the time

   • Whether HCFC2 is required for MLL complex enzymatic activity or target-gene selectivity was not tested
   • Relative contributions of HCFC2 versus HCF-1 within the complex were unclear
6. 2013 Medium

   Quantitative stoichiometry determination of human SET1/MLL complexes confirmed HCFC2 as a substoichiometric component, refining the model of complex composition.

   Evidence Label-free quantitative mass spectrometry of affinity-purified tagged complexes

   PMID:23508102

   Open questions at the time

   • Functional impact of HCFC2 stoichiometry on complex activity was not addressed
   • Whether HCFC2 and HCF-1 occupy the same or distinct MLL complexes was unresolved
7. 2017 High

   Three independent ENU alleles demonstrated that HCFC2 is essential for IRF1/IRF2-dependent transcription of Tlr3 and a broad set of interferon-regulated genes, directly linking it to innate antiviral immunity and in vivo host defense.

   Evidence Forward genetic ENU screen in mice, ChIP for IRF1/IRF2 at Tlr3 promoter, cytokine/IFN assays in macrophages, survival studies during influenza and HSV-1 infection

   PMID:28970238

   Open questions at the time

   • Whether HCFC2 recruits IRF1/IRF2 directly or via chromatin remodeling intermediates is unknown
   • The relationship between HCFC2's MLL complex membership and its IRF-dependent promoter function has not been tested
   • Human genetic validation of HCFC2 deficiency in immunodeficiency is lacking

• The mechanism by which HCFC2 facilitates IRF1/IRF2 binding — whether through direct protein–protein interaction, chromatin modification via MLL-mediated H3K4 methylation, or another route — remains unresolved, as does the structural basis for functional divergence from HCF-1.
• No crystal or cryo-EM structure of HCFC2 or its complexes
• No separation-of-function alleles distinguishing MLL complex roles from IRF coregulatory roles
• No human disease mutations reported